{"id":"NCT00556140","sponsor":"Massachusetts General Hospital","briefTitle":"The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression","officialTitle":"The Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in the Acute Treatment of Psychotic Major Depression: Efficacy and Tolerability","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-06","primaryCompletion":"2008-01","completion":"2008-01","firstPosted":"2007-11-09","resultsPosted":"2012-08-20","lastUpdate":"2012-08-20"},"enrollment":16,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Psychotic Depression"],"interventions":[{"type":"DRUG","name":"Aripiprazole","otherNames":["Abilify"]}],"arms":[{"label":"Major Depression with Psychotic Features","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to assess the safety and effectiveness of the combination of aripiprazole (Abilify) and selective serotonin reuptake inhibitors (SSRIs) in subjects with psychotic major depression.","primaryOutcome":{"measure":"Depression and Psychosis Response Rate","timeFrame":"Baseline and 7 weeks","effectByArm":[{"arm":"Major Depression With Psychotic Features","deltaMin":62.5,"sd":8.3}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["19142112"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":16},"commonTop":["Akathisia","Gastrointestinal distress","Fatigue","Sedation","Body aches"]}}